Roche Announces $2.4 B Acquisition of 89bio, Targeting Liver and Cardiometabolic Therapies
Roche (SWX: ROG, OTCMKTS: RHHBY) announced today that it will acquire 89bio, Inc. (NASDAQ: ETNB)...
NASDAQ: ETNB
89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China
U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and...